Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
Zenon HuczekKarol ZbrońskiKajetan GrodeckiPiotr ScisłoBartosz RymuzaJanusz KochmanMaciej DąbrowskiAdam WitkowskiWojciech WojakowskiRadosław ParmaAndrzej OchałaMarek GrygierAnna Olasińska-WiśniewskaAleksander AraszkiewiczDariusz JagielakDariusz CiećwierzDominika PuchtaKatarzyna PaczwaKrzysztof J FilipiakRadosław WilimskiMarian ZembalaGrzegorz OpolskiPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
In conclusion, obstructive CAD at baseline evaluation for TAVI has independent negative impact on short-term prognosis. However, neither baseline nor residual Ss values have prognostic ability in patients undergoing TAVI. Revascularization prior to TAVI seems to improve survival to levels comparable with patients without obstructive CAD at baseline.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- ejection fraction
- coronary artery disease
- end stage renal disease
- aortic valve replacement
- transcatheter aortic valve replacement
- patients undergoing
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- peritoneal dialysis
- type diabetes
- prognostic factors
- heart failure
- left ventricular
- patient reported outcomes
- patient reported